ValuentumAd

Official PayPal Seal














Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Feb 9, 2016
You Knew Anadarko’s Dividend Was at Tremendous Risk
Anadarko cut its dividend, to no surprise.
Feb 9, 2016
Alert: Health Care REITs Whacked
February 9 was a tough day for healthcare REITs. We’ll be parting with HCP.
Feb 9, 2016
Kinder Morgan, MLPs, and the Risk of $0
Valuentum’s Brian Nelson shares his analytical secrets and tips in an open seminar with Q&A. He’ll outline what he saw in the financials of Kinder Morgan that shocked him in June and what continues to worry him about MLPs today that prompted him to make such a controversial call to help investors avoid the collapse that has subsequently happened. There’s more, but we can’t give it all away in the teaser.
Feb 8, 2016
Dividend Increases/Decreases for the Week Ending February 5
Let's take a look at companies raising their dividends this week.
Feb 5, 2016
Three Blow Ups after the Close February 4
It won’t be pretty for shares of LinkedIn, Deckers, and Outerwall after their respective calendar fourth-quarter results.
Feb 4, 2016
Industrial Earnings Roundup
Let’s take a look at the results of some industrial companies in their most recent quarters.
Feb 3, 2016
Chipotle and Buffalo Wild Wings…Yikes!
Two fast-casual bellwethers are in a lot of pain.
Feb 2, 2016
Early Read: Gilead Guides Revenue to Decline in 2016, Below Consensus
The growth spurt may be over, and we’re most worried about the back half of this decade.
Feb 2, 2016
Best Idea Michael Kors Up 20%+ -- Yawn?
It’s good to see a recent add make a move such as this, but let’s cover other areas in this note as well.
Feb 1, 2016
Google…Ahem…Alphabet!
We’re still getting used to Google’s new name, but its performance is something we certainly can get used to.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.